Big Spending Republ...
Momenta Pharmaceuticals Inc. (MNTA: NASDAQ)
$16.16 0.04 | 0.25%
02/08/12 - 04:00 PM ET
615.46K / 836.70K
Vol / Avg. Vol:16.08 / 16.12
Open / Prev. Close:15.88 - 16.34
Today's Range:10.15 - 21.00
52 Wk Range:-7.30%
Performance YTD:TheStreet Rating:
Portfolios with MNTA
- Portfolio NameUser Type
- Contributor8 Pharma Stocks to Watch
- Contributor10 Stocks With Highest Prof...
- ContributorTop-Rated Biotechnology Stocks
- ProDiscovery Capital Management
- ContributorRelative Strength Stocks 09...
- UserMF
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- Contributor4 Drug Stocks Poised to Sta...
- Userbiotech
Latest MNTA Headlines from TheStreet
- UBS: 8 Pharma Stocks to Watch 01.20.12 | 12:01 pm
- Momenta Pharmaceuticals CEO Hosts Investor Conference Call To Discuss Follow-On Biologics Collaboration With Baxter (Transcript) 01.06.12 | 12:01 pm
- The Next Big Thing In Biotech: 2012 Outlook
01.06.12 | 05:01 am - 10 Stocks With Highest Profitability Ratios 01.04.12 | 10:01 am
- Eastman Kodak, Rambus: After-Hours Trading 12.22.11 | 05:12 pm
- 10 Biotech Stock Predictions for 2012 12.20.11 | 11:12 am
- Momenta Pharmaceuticals' Management Presents At Deutsche Bank BioFEST 2011 - Event Transcript 12.09.11 | 04:12 pm
- Momenta Pharmaceuticals Inc. Stock Upgraded (MNTA) 12.05.11 | 06:12 am
- Momenta Pharmaceuticals Inc. (MNTA): Today's Featured Health Care Winner 11.17.11 | 05:11 pm
- Momenta Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.07.11 | 12:11 pm
Press Releases for MNTA
- Baxter And Momenta Announce Collaboration To Develop And Commercialize Follow-On Biologics - Business Wire 12.22.11 | 04:12 pm
Partner Headlines for MNTA
- Verastem IPO Validates Investor Interest In Cancer Stem Cell Approach - Seeking Alpha 01.30.12 | 09:01 am
- S&P Indices Announces Change to US Index - Benzinga 01.28.12 | 05:01 pm
- UPDATE: Momenta Pharmaceuticals Motion for Preliminary Injunction Against Amphastar Pharmaceuticals & Watson Pharmaceuticals - Benzinga 01.26.12 | 01:01 pm
- Zacks Releases Four Powerful ''Buy'' Stocks: Momenta Pharmaceuticals, Lowe's Companies, Humana and Energy Partners Limited - Press Releases - Zacks 01.25.12 | 09:01 am
- Momenta Pharmaceuticals - Aggressive Growth - Zacks 01.25.12 | 01:01 am
- 12 Stocks for 2012 - Investment Ideas - Zacks 01.13.12 | 01:01 am
- Friday's Options Briefs: LVS, MNTA, CHS, KLIC, - Seeking Alpha 12.23.11 | 01:12 pm
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
- 10 Small-Cap Stocks With Strong Profitability And Plenty Of Cash On Hand - Seeking Alpha 11.04.11 | 08:11 am
- End-of-Day Market Summary for October 31, 2011 - Benzinga 10.31.11 | 04:10 pm





